AU2115197A - Compositions and methods useful in the detection and/or treatment of cancerous conditions - Google Patents

Compositions and methods useful in the detection and/or treatment of cancerous conditions

Info

Publication number
AU2115197A
AU2115197A AU21151/97A AU2115197A AU2115197A AU 2115197 A AU2115197 A AU 2115197A AU 21151/97 A AU21151/97 A AU 21151/97A AU 2115197 A AU2115197 A AU 2115197A AU 2115197 A AU2115197 A AU 2115197A
Authority
AU
Australia
Prior art keywords
compositions
detection
treatment
methods useful
cancerous conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21151/97A
Inventor
Judith P. Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melcorp Diagnostics Inc
Original Assignee
Melcorp Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melcorp Diagnostics Inc filed Critical Melcorp Diagnostics Inc
Publication of AU2115197A publication Critical patent/AU2115197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU21151/97A 1996-01-30 1997-01-30 Compositions and methods useful in the detection and/or treatment of cancerous conditions Abandoned AU2115197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59356396A 1996-01-30 1996-01-30
US593563 1996-01-30
PCT/US1997/001586 WO1997028193A1 (en) 1996-01-30 1997-01-30 Compositions and methods useful in the detection and/or treatment of cancerous conditions

Publications (1)

Publication Number Publication Date
AU2115197A true AU2115197A (en) 1997-08-22

Family

ID=24375221

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21151/97A Abandoned AU2115197A (en) 1996-01-30 1997-01-30 Compositions and methods useful in the detection and/or treatment of cancerous conditions

Country Status (2)

Country Link
AU (1) AU2115197A (en)
WO (1) WO1997028193A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322426A1 (en) * 1998-03-03 1999-09-10 Emory University Diagnostic for metastatic prostate cancer
US6824995B1 (en) 1998-03-03 2004-11-30 Emory University Diagnostic for metastatic prostate cancer
US20030009013A1 (en) 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1623991A3 (en) * 1999-09-01 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2425643A1 (en) * 2000-10-11 2002-04-18 Avalon Pharmaceuticals Cancer-linked genes as targets for chemotherapy
US7429241B2 (en) 2005-09-29 2008-09-30 Codman & Shurtleff, Inc. Dural graft and method of preparing the same

Also Published As

Publication number Publication date
WO1997028193A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
AU3978497A (en) Improvements in polymer compositions for chemotherapy and methods of treatment using the same
AU7812998A (en) Versatile stereotactic device and methods of use
AU2212299A (en) Compositions and methods for the treatment of tumor
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU2113295A (en) Novel compositions and methods for water treatment
AU5522798A (en) Water-responsive polymer compositions and method of making the same
PL330713A1 (en) Spry-dried compositions of polymers and treatment methods
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU4003597A (en) Methods of diagnosing and treating cancer
AU2821295A (en) Compositions and methods for the treatment of tumors
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
AU4608296A (en) Methods and compositions for treatment of solid tumors in vivo
AU3118297A (en) Sok-1 and methods of use
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions
AU1829097A (en) Methods for regenerating scarless skin and compositions used therein
AU2750297A (en) Methods for prevention and/or treatment of neutropenia
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU3061199A (en) Skin treatment compositions and the use thereof
AU3103097A (en) Compositions and methods for the treatment of chronic infections
AU2708597A (en) An improvement in the treatment of wastes
AU5939898A (en) Agent for the pre-symptomatic detection, prevention and treatment of breast cancer in humans
AU2351699A (en) The human calcium-sensing receptor in the detection and treatment of cancer